ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $402 | -86.0% | 14,962 | -81.4% | 0.00% | -85.2% |
| Q2 2023 | $2,872 | +614.4% | 80,539 | +408.3% | 0.03% | +440.0% |
| Q1 2023 | $402 | -100.0% | 15,846 | -37.9% | 0.01% | -50.0% |
| Q2 2022 | $898,000 | -56.8% | 25,521 | -23.4% | 0.01% | -23.1% |
| Q3 2021 | $2,078,000 | -38.1% | 33,301 | -17.9% | 0.01% | -58.1% |
| Q2 2021 | $3,357,000 | -33.4% | 40,538 | -38.3% | 0.03% | -69.3% |
| Q4 2020 | $5,037,000 | -73.5% | 65,649 | -78.1% | 0.10% | -87.6% |
| Q4 2019 | $18,984,000 | +6957.2% | 299,297 | +2842.1% | 0.82% | +4700.0% |
| Q2 2019 | $269,000 | -21.3% | 10,173 | -63.1% | 0.02% | -65.3% |
| Q4 2018 | $342,000 | – | 27,593 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,303 | $54,386,000 | 28.54% |
| JOHNSON & JOHNSON | 3,260,869 | $216,196,000 | 24.61% |
| ACT CAPITAL MANAGEMENT, LLC | 210,500 | $13,956,000 | 10.09% |
| Aquilo Capital Management, LLC | 700,426 | $46,438,000 | 5.27% |
| WEALTH EFFECTS LLC | 145,960 | $9,677,000 | 4.02% |
| Evolutionary Tree Capital Management, LLC | 115,580 | $7,663,000 | 3.68% |
| ACUTA CAPITAL PARTNERS, LLC | 105,500 | $6,995,000 | 2.94% |
| Privium Fund Management B.V. | 204,393 | $13,766,000 | 2.73% |
| L1 Capital Pty Ltd | 292,735 | $19,408,000 | 2.24% |
| Avidity Partners Management LP | 875,000 | $58,013,000 | 1.23% |